Public trial registry of the CCC-Munich

Trial OSAG

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
OSAG
World
Full title
:

Phase-III study of standard radiotherapy plus concomitant and adjuvant OSAG 101 (Theraloc ) plus Temozolomide vs. standard radiotherapy plus concomitant and adjuvant Temozolomide in patient with newly diagnosed, histologically confirmed glioblastoma multiforme grade IV

World
NCT number
:
00753246
World
Responsible organization
:
Neurochirurgische Klinik, Telefon: 089440073550
Indications
Classification Code Description
ICD-10-GM C71.- Bösartige Neubildung des Gehirns
- CNS Tumors
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Double blinded
World
Phase
:
III
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2012-01-31 / Unknown
Participants
Function Prename Surname Organization
World Principal Investigator Joerg-Christian Tonn Keine Organisationseinheit angegeben Magnifier
Printer
 
Application_get